Gomez, Kimberly
Ran, Dongzhi
Madura, Cynthia L.
Moutal, Aubin
Khanna, Rajesh http://orcid.org/0000-0002-9066-2969
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (NS098772, NS120663)
National Institute on Drug Abuse (DA042852)
Article History
Received: 30 September 2020
Accepted: 7 December 2020
First Online: 21 January 2021
Ethics approval and consent to participate
: Not applicable.
: The University of Arizona’s College of Medicine Institutional Animal Care and Use Committee (IACUC) sanctioned all experiments.
: Not applicable.
: R. Khanna is the co-founder of Regulonix LLC, a company developing non-opioids drugs for chronic pain. In addition, R. Khanna has patents US10287334 and US10441586 issued to Regulonix LLC. R. The other authors declare no competing financial interest.